Consumer Driven Health Care

Aetna, Elevance Health and Kaiser Permanente will cover Wegovy to reduce heart attack risk in Medicare patients with heart conditions, following the FDA's approval of the drug to reduce stroke or heart attack risk in March.

Senator Bernie Sanders, who cites a Yale study that found an Ozempic dose costs Novo Nordisk less than $5 a month to manufacture, wants to meet with the drugmaker's CEO to discuss the drug's costs.

Larry Krasner, Philadelphia's district attorney, filed a lawsuit against Eli Lilly, Novo Nordisk and other drugmakers and pharmacy benefit managers, on behalf of the 1.1 million Pennsylvanians who have diabetes, like himself.

Last fall, the Biden administration issued an executive order giving the Department of Health and Human Services the daunting task of putting guardrails around increasingly advanced artificial intelligence health care models.

With one estimate predicting women will account for close to half of the disease costs in the U.S. by 2040 – a $66 billion price tag – it's a high-priority topic for the Biden administration and HHS, which will soon release guidelines.

Employers emphasize an increase in health and dental insurance, while employees say increased pay and 401(k) matches are tops, and this could be part of the ongoing issue of high turnover, a new study suggests.